YXYaohua Xue

Yaohua Xue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yaohua Xue has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Heping Zheng

    Affiliations Dermatology Hospital, Southern Medical University, Guangzhou, China, Guangzhou Key Laboratory for Sexually Transmitted Diseases Control, Guangzhou, China, Institute for Global Health, Southern Medical University, Guangzhou, China

    2 shared publications
  • Zhili Rong

    Cancer Research Institute, School of Basic Medical Sciences, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Province Key Laboratory of Immune Regulation and Immunotherapy, Southern Medical University, Guangzhou, China

    2 shared publications
  • Bin Yang

    Dermatology Hospital of Southern Medical University Guangzhou Guangdong China

    1 shared publication
  • Bowen Shu

    BDermatology Hospital, Southern Medical University, Guangzhou 510091, China

    1 shared publication
  • Cheng-Cheng Deng

    Dermatology Hospital, Southern Medical University, Guangzhou, China

    1 shared publication
  • Chengsong Wan

    Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China

    1 shared publication

Latest Publications

  • Open Access

    Baicalin potentiates antibiotic efficacy against resistant Neisseria gonorrhoeae by inhibiting outer membrane vesicle secretion

    by Xiao-Lin Qin, Xiaoxiao Li, Mingjing Liu, Xing-Zhong Wu, Jiang-Li Ou, Sanmei Tang, Dan Liu, Qing-Xian Zhan, Mingzhou Xiong, Yaohua Xue, et al.

    Escalating antimicrobial resistance has positioned Neisseria gonorrhoeae as a high-priority pathogen, underscoring the urgent need for novel antibacterials and alternative therapeutics. Baicalin, a natural flavonoid, is known to exhibit antibacterial activity. Here, we showed that baicalin exerted direct antibacterial activity against drug‐resistant N. gonorrhoeae with minimum inhibitory concentration (MIC) values ranging from 0.06 to 16 mg/mL. Combination of baicalin at low concentrations with various antibiotics exhibited synergistic antibacterial activity, particularly with penicillin, yielding the lowest fractional inhibitory concentration index of 0.13 and reducing the MIC of penicillin by up to 32‐fold. In a murine model, oral co‐administration of baicalin and penicillin significantly reduced vaginal bacterial load and attenuated uterine inflammation compared with either monotherapy. Mechanistically, baicalin upregulated the expression of MlaA, a key regulator of outer membrane vesicle (OMV) biogenesis, thereby suppressing penicillin‐induced OMV secretion and enhancing intracellular penicillin accumulation. Taken together, these results suggest that baicalin functions as an MlaA inducer to inhibit OMV secretion, thereby potentiating the activity of multiple antibiotics against resistant N. gonorrhoeae, and may represent a promising adjunctive candidate for treating gonococcal infections.

  • Epidemiology and antimicrobial resistance of Mycoplasma genitalium among female sex workers in China: a cross-sectional study

    by Jiangmin Lu, Peizhen Zhao, Liji Liang, Fangyuan Zheng, Qingqing Xu, Yuzhen Chen, Shujie Huang, Bowen Shu, Mingzhou Xiong, Wentao Chen, et al.

    Background: Mycoplasma genitalium (MG) is an important sexually transmitted pathogen associated with cervicitis, pelvic inflammatory disease and adverse reproductive outcomes. Female sex workers (FSWs) are at elevated risk; however, data on MG epidemiology and antimicrobial resistance in this population in China remain limited. This study assessed the prevalence of MG infection, associated risk factors and resistance-related mutations among FSWs. Methods: This cross-sectional study was conducted from April to August 2022 in four cities in Guangdong Province. FSWs were recruited through venue-based outreach. Participants completed structured questionnaires covering sociodemographic characteristics and sexual behaviors. Urine and blood samples were collected for laboratory confirmation of MG, Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum and HIV. MG-positive specimens were subjected to Sanger sequencing to detect macrolide resistance mutations in the 23S rRNA gene, and fluoroquinolone resistance mutations in the gyrA and parC genes. Logistic regression analyses were used to identify factors associated with MG infection. Results: Among 955 FSWs, the prevalence of MG was 6.6%, whereas the prevalences of C. trachomatis, N. gonorrhoeae, T. pallidum and HIV were 14.0%, 1.7%, 1.4% and 0.1%, respectively. Multivariate logistic regression analysis revealed higher odds of MG infection among women with monthly income ≤3000 RMB (aOR 2.61, 95% CI: 1.08–6.31), primary school education or below (aOR 2.87, 95% CI: 1.12–7.37), work in mid-level venues (aOR 2.64, 95% CI: 1.37–5.09) and C. trachomatis co-infection (aOR 3.30, 95% CI: 1.81–6.01). Among MG-positive samples with successful amplification, macrolide resistance-associated mutations in the 23S rRNA gene were detected in 70.27% (26/37). Fluoroquinolone resistance-associated mutations were identified in 78.95% (30/38) of amplifiable parC samples and in only one amplifiable gyrA sample. The S83I substitution in parC was the most prevalent, accounting for 66.67% (20/30) of parC mutations. Dual resistance-conferring mutations in both macrolide (23S rRNA) and fluoroquinolone (parC) targets were observed in 51.35% (19/37) of samples. Conclusion: MG infection persists at a relatively high level among FSWs, accompanied by alarmingly high rates of macrolide and fluoroquinolone resistance mutations. These findings highlight the urgent need for strengthened surveillance, improved access to molecular diagnostics, and tailored prevention and treatment strategies to curb MG transmission and preserve antimicrobial efficacy in this high-risk population.

  • Open Access

    Inhibition of the Extracellular Signal–Regulated Kinase/Ribosomal S6 Kinase Cascade Limits Chlamydia trachomatis Infection

    by Yaohua Xue, Wentao Chen, Zhida Mai, Xueying Yu, Qian Wu, Chengsong Wan, Xin Su, Yiquan Wu, Zhili Rong, Heping Zheng


  • TRAF4 Promotes Fibroblast Proliferation in Keloids by Destabilizing p53 via Interacting with the Deubiquitinase USP10

    by Cheng-Cheng Deng, Ding-Heng Zhu, Yong-Jun Chen, Tao-Yuan Huang, Yang Peng, Si-Ya Liu, Ping Lu, Yao-Hua Xue, Ying-Ping Xu, Bin Yang, et al.